CNTN5 and Alzheimer disease: PrPC was significantly reduced in sporadic AD by a mean of 49% (p = 0.014) compared to the age matched controls (Figure 1A and B, Table 1) but there was no significant difference in CNTN5 between sporadic AD and controls (Figure 1C and D, Table 1).